Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Campbell

Showing results (71-80 of 240) with videos related to

Pageof 24
Sort By:
Life Science Alliance|March 20, 2023
MicroRNAs in tear fluids predict underlying molecular changes associated with Alzheimer's diseasePrintha Wijesinghe, Jeanne Xi, Jing Cui, et al.
BMC Genomics|October 27, 2007
EuCAP, a Eukaryotic Community Annotation Package, and its application to the rice genomeFrançoise Thibaud-Nissen, Matthew Campbell, John P Hamilton, et al.
Diabetes, Obesity & Metabolism|August 3, 2019
Double diabetes: A distinct high-risk group?Noppadol Kietsiriroje, Sam Pearson, Matthew Campbell, et al.
Current Eye Research|December 16, 2006
Involvement of MAPKs in endostatin-mediated regulation of blood-retinal barrier functionMatthew Campbell, Ross Collery, Alice McEvoy, et al.
International Journal of Health Policy and Management|December 18, 2015
Introducing New Priority Setting and Resource Allocation Processes in a Canadian Healthcare Organization: A Case Study Analysis Informed by Multiple Streams TheoryNeale Smith, Craig Mitton, Laura Dowling, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
The mitochondrial-targeted peptide therapeutic elamipretide improves cardiac and skeletal muscle function during aging without detectable changes in tissue epigenetic or transcriptomic ageWayne Mitchell, Gavin Pharaoh, Alexander Tyshkovskiy, et al.
Aging Cell|March 13, 2025
The Mitochondria-Targeted Peptide Therapeutic Elamipretide Improves Cardiac and Skeletal Muscle Function During Aging Without Detectable Changes in Tissue Epigenetic or Transcriptomic AgeWayne Mitchell, Gavin Pharaoh, Alexander Tyshkovskiy, et al.
Fluids and Barriers of the CNS|September 28, 2024
NX210c drug candidate peptide strengthens mouse and human blood-brain barriersChris Greene, Nicolas Rebergue, Gwen Fewell, et al.
Current Opinion in Oncology|February 3, 2017
Recent developments in the management of germ cell tumorsPavlos Msaouel, Mehmet A Bilen, Miao Zhang, et al.
Advances in Experimental Medicine and Biology|March 26, 2014
Inflammation in age-related macular degenerationEma Ozaki, Matthew Campbell, Anna-Sophia Kiang, et al.
Pageof 24

Showing results (71-80 of 240) with videos related to

Sort By:
Pageof 24
Life Science Alliance|March 20, 2023
MicroRNAs in tear fluids predict underlying molecular changes associated with Alzheimer's diseasePrintha Wijesinghe, Jeanne Xi, Jing Cui, et al.
BMC Genomics|October 27, 2007
EuCAP, a Eukaryotic Community Annotation Package, and its application to the rice genomeFrançoise Thibaud-Nissen, Matthew Campbell, John P Hamilton, et al.
Diabetes, Obesity & Metabolism|August 3, 2019
Double diabetes: A distinct high-risk group?Noppadol Kietsiriroje, Sam Pearson, Matthew Campbell, et al.
Current Eye Research|December 16, 2006
Involvement of MAPKs in endostatin-mediated regulation of blood-retinal barrier functionMatthew Campbell, Ross Collery, Alice McEvoy, et al.
International Journal of Health Policy and Management|December 18, 2015
Introducing New Priority Setting and Resource Allocation Processes in a Canadian Healthcare Organization: A Case Study Analysis Informed by Multiple Streams TheoryNeale Smith, Craig Mitton, Laura Dowling, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
The mitochondrial-targeted peptide therapeutic elamipretide improves cardiac and skeletal muscle function during aging without detectable changes in tissue epigenetic or transcriptomic ageWayne Mitchell, Gavin Pharaoh, Alexander Tyshkovskiy, et al.
Aging Cell|March 13, 2025
The Mitochondria-Targeted Peptide Therapeutic Elamipretide Improves Cardiac and Skeletal Muscle Function During Aging Without Detectable Changes in Tissue Epigenetic or Transcriptomic AgeWayne Mitchell, Gavin Pharaoh, Alexander Tyshkovskiy, et al.
Fluids and Barriers of the CNS|September 28, 2024
NX210c drug candidate peptide strengthens mouse and human blood-brain barriersChris Greene, Nicolas Rebergue, Gwen Fewell, et al.
Current Opinion in Oncology|February 3, 2017
Recent developments in the management of germ cell tumorsPavlos Msaouel, Mehmet A Bilen, Miao Zhang, et al.
Advances in Experimental Medicine and Biology|March 26, 2014
Inflammation in age-related macular degenerationEma Ozaki, Matthew Campbell, Anna-Sophia Kiang, et al.
Pageof 24